Physician profile
Bridget L Gresback
NPI 1831786714
$840.73
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $477 · 2022: $297 · 2023: $67.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $211.74 | 2022-2023 | Myrbetriq |
| Janssen Biotech, INC. | $123.78 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $123.23 | 2021 | |
| Urogen Pharma, INC. | $121.30 | 2021 | |
| Myovant Sciences INC. | $108.20 | 2021 | |
| Urovant Sciences INC | $93.57 | 2022 | |
| Boston Scientific Corporation | $30.89 | 2023 | |
| Axonics, INC. | $15.11 | 2022 | |
| Sumitomo Pharma America, INC. | $12.91 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Gresback listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.